AgroSpheres opens Virginia biomanufacturing plant as crop input production shifts onshore

AgroSpheres has opened a commercial biomanufacturing facility in Charlottesville, as agricultural technology companies seek to expand domestic production of biological crop inputs and reduce reliance on imported chemical ingredients.

The 12,500-square-foot site includes a commercial-scale fermentation operation—an area where U.S. capacity remains constrained relative to demand from biotechnology firms. Industry participants have increasingly pointed to a shortage of domestic infrastructure, with some companies relying on overseas partners for production.

The facility is designed to support current output and future expansion, with capacity to treat hundreds of thousands of acres annually. AgroSpheres plans to scale production further as it advances additional products in development.

The Charlottesville-based company develops biological crop protection products using its AgriCell platform, which it says enables the delivery of active ingredients at lower doses. Its first commercial product, a thyme oil-based biofungicide, has received approvals in multiple U.S. states and is being used by some specialty crop growers, including vineyards.

The project received support from state and local economic development programs in Virginia, including grants and workforce training initiatives. Virginia Governor Abigail Spanberger attended the facility’s opening and said the investment aligns with the state’s focus on agricultural innovation and supply chain resilience.

AgroSpheres has invested about $10 million in the project to date and plans to increase that to $25 million while expanding its workforce over the remainder of the decade.